Inventiva (IVA) Interest & Investment Income (2019 - 2024)
Inventiva's (IVA) quarterly Interest & Investment Income came in at $5.6 million in Q4 2024, up 52.23% year-on-year from $3.7 million in Q1 2024, and up 30.75% quarter-over-quarter from $4.3 million in Q2 2024.
Inventiva (IVA) Interest & Investment Income (2019 - 2024) Analysis & Trends
Inventiva's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $5.6 million for Q4 2024.
- On a quarterly basis, Interest & Investment Income rose 52.23% year-over-year to $5.6 million in Q4 2024; TTM through Dec 2024 was $5.6 million, a 52.23% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, down 12.98% from the prior year.
- Interest & Investment Income climbed to $5.6 million in Q4 2024 per IVA's latest filing, from $4.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.6 million in Q4 2024 and bottomed at $22078.8 in Q1 2020.
- The 4-year median for Interest & Investment Income is $2.8 million (2023), against an average of $2.7 million.
- Across the five-year window, Interest & Investment Income soared 20026.9% in 2021 and jumped 52.23% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $30840.9 in 2020, then soared by 6073.47% to $1.9 million in 2021, then surged by 92.42% to $3.7 million in 2023, then soared by 52.23% to $5.6 million in 2024.
- Per Business Quant, the three latest IVA Interest & Investment Income figures stand at $5.6 million (Q4 2024), $4.3 million (Q2 2024), and $3.7 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Inventiva | 854.62 Mn | 854.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.58 Mn |
| Jun 30, 2024 | 4.27 Mn |
| Dec 31, 2023 | 3.66 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 4.44 Mn |
| Jun 30, 2020 | 30,840.88 |
| Mar 31, 2020 | 22,078.78 |
| Dec 31, 2019 | 169,353.81 |